儿童的再生血管高血压
Kjell Tullus1, Eileen Brennan, George Hamilton
1Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Trust, London, UK. tulluk@gosh.nhs.uk
Lancet (London, England)
|April 29, 2008
概括
血管疾病是儿科高血压的罕见原因,经常面临诊断延迟. 及时干预,包括内血管程序或手术,可以有效地管理儿童的高血压.
科学领域:
- 儿科脏病学 儿科脏病学
- 血管医学 血管医学
- 心脏病学 心脏病学
背景情况:
- 血管疾病是儿童高血压的不常见但重要的原因.
- 由于血压监测不频繁,以及儿科患者高读数的驳回,延迟诊断是常见的.
- 其他主要血管的相关异常常见于患有血管疾病的儿童.
研究的目的:
- 总结儿童血管疾病的诊断和治疗方法.
- 突出早期检测和多学科管理的重要性.
- 审查当前治疗方式的有效性.
主要方法:
- 对诊断成像技术的审查,包括CT,MRI和脏扫描与血管酶转化酶抑制.
- 血管造影作为诊断的黄金标准.
- 讨论干预和手术治疗选择.
主要成果:
- 带有或没有支架的内血管治疗在超过50%的受影响儿童中成功治疗或降低高血压.
- 建议在必要时进行手术干预,最好延迟到骨成熟.
- 多学科的团队管理带来了有利的长期结果.
结论:
- 早期识别和及时干预对于管理儿科血管高血压至关重要.
- 内血管和外科治疗都提供了显著的好处.
- 涉及儿科脏病学家,干预放射学家和血管外科医生的协作方法优化了长期的结果.
相关概念视频
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

